Open-label, Single Arm Trial of BI 695502 in Patients With Previously Untreated Metastatic Colorectal Cancer
Ontology highlight
ABSTRACT: The objective of this trial is to evaluate the safety and tolerability of BI 695502 in combination with leucovorin/5-fluorouracil/oxaliplatin (mFOLFOX6) and as maintenance therapy (when applicable). As well as to evaluate the following efficacy parameters: Progression-free survival (PFS), objective response rate (proportion of patients with complete response [CR] plus partial response [PR]), overall survival (OS), duration of response (DOR), time to progression (TTP).
DISEASE(S): Metastatic Colorectal Cancer,Previously Untreated Locally Advanced Or Metastaticcolorectal Cancer,Cáncer Colorrectal Localmente Avanzado Ometastásico No Tratado Previamente,Colorectal Neoplasms,Colorectal Cancer Metastatic
PROVIDER: 2215487 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA